AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $0
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.10pm 07/08/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | $2.30 | Day High | $2.39 | Day Low | $2.30 | |||
| Daily Volume | 33959 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | $2.33 | 3759 | 0 | $2.38 | 1569 | |
Directors & Senior Management
| Dr. David Kenneth Hobday | Portfolio Manager and Member of Investment Committee |
| Mr. Michael Peter Chester | Portfolio Manager and Member of Investment Committee |
| Mr. Peter R. Mitchell | Portfolio Manager and Member of Investment Committee |
Data source: ADVFN
